| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2015) |
C. Warren [États-Unis] ; Raymond. Bartus [États-Unis] ; Tiffany. Baumann [États-Unis] ; Stewart Factor [États-Unis] ; Nicholas Boulis [États-Unis] ; Mark Stacy [États-Unis] ; Dennis. Turner [États-Unis] ; William Marks [États-Unis] ; Paul Larson [États-Unis] ; Phillip. Starr [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard Simpson [États-Unis] ; Ray Watts [États-Unis] ; Barton Guthrie [États-Unis] ; Kathleen Poston [États-Unis] ; Jaimie. Henderson [États-Unis] ; Matthew Stern [États-Unis] ; Gordon Baltuch [États-Unis] ; Christopher. Goetz [États-Unis] ; Christopher Herzog [États-Unis] ; Jeffrey. Kordower [États-Unis] ; Ron Alterman [États-Unis] ; Andres. Lozano [Canada] ; Anthony. Lang [Canada] | Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. |
| 000024 (2014) |
Joseph Jankovic [États-Unis] ; Elijahu Berkovich [Israël] ; Eli Eyal [Israël] ; Eduardo Tolosa [Espagne] | Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial. |
| 000026 (2014) |
Rajesh Pahwa [États-Unis] ; Kelly. Lyons [États-Unis] ; Robert. Hauser [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Emmanuelle Pourcher [Canada] ; Ann Hsu [États-Unis] ; Martin O [États-Unis] ; Sherron Kell [États-Unis] ; Suneel Gupta [États-Unis] | Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. |
| 000031 (2014) |
Sotirios. Parashos [États-Unis] ; Sheng Luo ; Kevin. Biglan [États-Unis] ; Ivan Bodis ; Bo He ; Grace. Liang [États-Unis] ; G Ross [États-Unis] ; Barbara. Tilley ; Lisa. Shulman [États-Unis] | Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. |
| 000036 (2014) |
Nir Giladi [Israël] ; Liesbet Ghys [Belgique] ; Erwin Surmann [Allemagne] ; Babak Boroojerdi [États-Unis] ; Joseph Jankovic [États-Unis] | Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease. |
| 000039 (2014) |
Anthony. Nicholas [États-Unis] ; Rupam Borgohain [Inde] ; Pedro Chaná [Chili] ; Erwin Surmann [Allemagne] ; Emily. Thompson [Royaume-Uni] ; Lars Bauer [Allemagne] ; John Whitesides [États-Unis] ; Lawrence. Elmer [États-Unis] | A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease. |
| 000042 (2013) |
Peter. Lewitt [États-Unis] ; Babak Boroojerdi ; Erwin Surmann ; Werner Poewe | Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER. |
| 000054 (2012) |
Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Mouradian ; Wolfgang. Oertel ; C Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. |
| 000058 (2012) |
Lawrence. Elmer [États-Unis] ; Erwin Surmann ; Babak Boroojerdi ; Joseph Jankovic [États-Unis] | Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study. |
| 000063 (2012) |
Jordan. Elm [États-Unis] | Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. |
| 000083 (2011) |
Olivier Rascol [France] ; Cheryl. Fitzer ; Robert Hauser ; Joseph Jankovic [États-Unis] ; Anthony Lang ; J Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa ; Eli Eyal ; Yoni. Weiss ; C Olanow | A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. |
| 000093 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa ; Paulo Barone ; Anthony. Lang ; C Olanow | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. |
| 000094 (2010) |
Rodger. Elble [États-Unis] ; Oksana Suchowersky ; Stephanie Shaftman ; William. Weiner ; Peng Huang ; Barbara Tilley | Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. |
| 000098 (2010) |
William. Marks [États-Unis] ; Raymond. Bartus ; Joao Siffert ; Charles. Davis ; Andres Lozano ; Nicholas Boulis ; Jerrold Vitek ; Mark Stacy ; Dennis Turner ; Leonard Verhagen ; Roy Bakay ; Raymond Watts ; Barton Guthrie ; Joseph Jankovic [États-Unis] ; Richard Simpson ; Michele Tagliati ; Ron Alterman ; Matthew Stern ; Gordon Baltuch ; Philip. Starr ; Paul. Larson ; Jill. Ostrem ; John Nutt ; Karl Kieburtz ; Jeffrey. Kordower ; C Olanow | Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. |
| 000101 (2010) |
Steven. Schwid [États-Unis] ; Janice Bausch ; David Oakes ; Lynn Schuchter ; Caroline Tanner ; Misser Forrest ; Anthony. Lang ; Ira Shoulson ; Ira Shoulson ; Christopher Hyson ; David Oakes ; Emily Flagg ; Alice Rudolph ; Karl Kieburtz ; Anthony Lang ; Stanley Fahn ; Lisa Gauger ; Christopher Goetz | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. |
| 000126 (2009) |
Joseph Jankovic [États-Unis] | Atomoxetine for freezing of gait in Parkinson disease. |
| 000128 (2009) |
C Olanow [États-Unis] ; Olivier Rascol ; Robert Hauser ; Paul. Feigin ; Joseph Jankovic [États-Unis] ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa | A double-blind, delayed-start trial of rasagiline in Parkinson's disease. |
| 000129 (2009) |
Connie Marras [Canada] ; Anthony. Lang ; Shirley. Eberly ; David Oakes ; Stanley Fahn ; Steven. Schwid ; Christopher Hyson ; Ira Shoulson | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. |
| 000133 (2008) |
Michael. Schwarzschild [États-Unis] ; Steven. Schwid ; Kenneth Marek ; Arthur Watts ; Anthony. Lang ; David Oakes ; Ira Shoulson ; Alberto Ascherio ; Christopher Hyson ; Emily Gorbold ; Alice Rudolph ; Karl Kieburtz ; Stanley Fahn ; Lisa Gauger ; Christopher Goetz ; John Seibyl ; Misser Forrest ; John Ondrasik | Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. |
| 000142 (2008) |
G. Schifitto [États-Unis] ; J Friedman ; D. Oakes ; L. Shulman ; C Comella ; K. Marek ; S. Fahn | Fatigue in levodopa-naive subjects with Parkinson disease. |
| 000150 (2008) |
C Olanow [États-Unis] ; Robert. Hauser ; Joseph Jankovic [États-Unis] ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol | A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. |
